Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Mar-17 12:37 PM View:  | Goldberg Shepard M Director | Echo Therapeutics, Inc. (ECTE) | 21-Mar-17 | Grant | 25,000 | -- | -- | 345% 7.25K to 32.25K | |
| 23-Mar-17 12:38 PM View: | Goldberg Michael M Director | Echo Therapeutics, Inc. (ECTE) | 21-Mar-17 | Grant | 25,000 | -- | -- | 172% 14.5K to 39.5K | |
| 22-Mar-17 3:57 PM View: | Schoenbart Alan Wayne CEO, CFO AND SECRETARY Director | Echo Therapeutics, Inc. (ECTE) | 21-Mar-17 | Grant | 100,000 | -- | -- | 134% 74.5K to 174.5K | |
| 22-Mar-17 3:55 PM View: | Schoenbart Alan Wayne CEO, CFO AND SECRETARY Director | Echo Therapeutics, Inc. (ECTE) | 25-Nov-16 | Payment of Exercise | 28,000 | $0.34 | $9,520.00 | (27%) 102.5K to 74.5K | 52% |
| 03-Mar-16 2:43 PM View: | Hollander Scott Wayne President and CEO Director | Echo Therapeutics, Inc. (ECTE) | 01-Mar-16 | Grant | 150,000 | -- | -- | 1875% 8.0K to 158.0K | |
| 03-Mar-16 2:35 PM View: | Schoenbart Alan Wayne INTERIM CEO, CFO AND SECRETARY | Echo Therapeutics, Inc. (ECTE) | 01-Mar-16 | Grant | 100,000 | -- | -- | 4000% 2.5K to 102.5K | |
| 20-May-15 4:29 PM View: | Schoenbart Alan Wayne CFO and Secretary | Echo Therapeutics, Inc. (ECTE) | 20-May-15 | Market Purchase | 2,500 | $1.44 | $3,600.00 | 100% 0 to 2.5K | (82%) |
| 20-May-15 4:28 PM View: | Hollander Scott Wayne President and CEO Director | Echo Therapeutics, Inc. (ECTE) | 20-May-15 | Market Purchase | 8,000 | $1.48 | $11,840.00 | 100% 0 to 8.0K | (83%) |
| 14-Jul-14 5:20 PM View: | Goldberg Shepard M Director | Echo Therapeutics, Inc. (ECTE) | 10-Jul-14 | Grant | 7,250 | -- | -- | 100% 0 to 7.25K | |
| 01-Jul-14 6:24 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 30-Jun-14 | Market Purchase | 55,083 | $2.20 | $121,183.00 | 2% 2.23M to 2.28M | (88%) |
| 01-Jul-14 6:24 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 27-Jun-14 | Market Purchase | 10,656 | $2.20 | $23,443.20 | < 1% 2.22M to 2.23M | (88%) |
| 27-Jun-14 5:31 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 26-Jun-14 | Market Purchase | 15,000 | $2.20 | $33,000.00 | < 1% 2.2M to 2.22M | (88%) |
| 27-Jun-14 5:31 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 25-Jun-14 | Market Purchase | 2,300 | $2.20 | $5,060.00 | < 1% 2.2M to 2.2M | (88%) |
| 24-Jun-14 6:18 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 24-Jun-14 | Market Purchase | 386 | $2.20 | $849.20 | < 1% 2.2M to 2.2M | (88%) |
| 24-Jun-14 6:18 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 23-Jun-14 | Market Purchase | 85 | $2.20 | $187.00 | < 1% 2.2M to 2.2M | (88%) |
| 24-Jun-14 6:18 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 20-Jun-14 | Market Purchase | 16,490 | $2.20 | $36,271.40 | < 1% 2.18M to 2.2M | (88%) |
| 17-Mar-14 1:22 PM View: | Goldberg Michael M Director | Echo Therapeutics, Inc. (ECTE) | 28-Feb-14 | Grant | 14,500 | -- | -- | 100% 0 to 14.5K | |
| 03-Jan-14 4:30 PM View: | Enright Vincent D Director | Echo Therapeutics, Inc. (ECTE) | 18-Dec-13 | Grant | 14,500 | -- | -- | 106% 13.7K to 28.2K | |
| 03-Jan-14 4:30 PM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 18-Dec-13 | Grant | 14,500 | -- | -- | 61% 23.7K to 38.2K | |
| 03-Jan-14 4:30 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 18-Dec-13 | Grant | 14,500 | -- | -- | 173% 8.4K to 22.9K | |
| 12-Dec-13 5:26 PM View: | Nordlicht Mark 10% Owner | Echo Therapeutics, Inc. (ECTE) | 10-Dec-13 | Market Purchase | 69,569 | $2.75 | $191,315.00 | 7% 1.02M to 1.09M | (91%) |
| 02-Oct-13 2:00 PM View: | Doman Robert F EXEC. CHAIRMAN AND INTERIM CEO Director | Echo Therapeutics, Inc. (ECTE) | 01-Oct-13 | Grant | 400 | -- | -- | 9% 4.3K to 4.7K | |
| 02-Oct-13 2:00 PM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 01-Oct-13 | Grant | 400 | -- | -- | 2% 23.3K to 23.7K | |
| 02-Oct-13 2:00 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 01-Oct-13 | Grant | 400 | -- | -- | 5% 8.0K to 8.4K | |
| 02-Oct-13 2:00 PM View: | Enright Vincent D Director | Echo Therapeutics, Inc. (ECTE) | 01-Oct-13 | Grant | 400 | -- | -- | 3% 13.3K to 13.7K | |
| 02-Jul-13 4:30 PM View: | Enright Vincent D Director | Echo Therapeutics, Inc. (ECTE) | 01-Jul-13 | Grant | 400 | -- | -- | < 1% 129.0K to 129.4K | |
| 02-Jul-13 4:30 PM View: | Doman Robert F Director | Echo Therapeutics, Inc. (ECTE) | 01-Jul-13 | Grant | 400 | -- | -- | 1% 39.0K to 39.4K | |
| 02-Jul-13 4:30 PM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 01-Jul-13 | Grant | 400 | -- | -- | < 1% 229.0K to 229.4K | |
| 02-Jul-13 4:30 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 01-Jul-13 | Grant | 400 | -- | -- | < 1% 76.0K to 76.4K | |
| 10-Apr-13 4:46 PM View: | Enright Vincent D Director | Echo Therapeutics, Inc. (ECTE) | 09-Apr-13 | Grant | 4,000 | -- | -- | 3% 125.0K to 129.0K | |
| 10-Apr-13 4:50 PM View: | Doman Robert F Director | Echo Therapeutics, Inc. (ECTE) | 09-Apr-13 | Grant | 4,000 | -- | -- | 11% 35.0K to 39.0K | |
| 10-Apr-13 4:48 PM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 09-Apr-13 | Grant | 4,000 | -- | -- | 2% 225.0K to 229.0K | |
| 10-Apr-13 4:50 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 09-Apr-13 | Grant | 4,000 | -- | -- | 6% 72.0K to 76.0K | |
| 25-Mar-13 2:03 PM View: | Doman Robert F Director | Echo Therapeutics, Inc. (ECTE) | 22-Mar-13 | Market Purchase | 15,000 | $0.80 | $11,961.00 | 75% 20.0K to 35.0K | (97%) |
| 22-Mar-13 4:45 PM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 21-Mar-13 | Market Purchase | 30,000 | $0.76 | $22,779.00 | 15% 195.0K to 225.0K | (97%) |
| 14-Mar-13 4:45 PM View: | Doman Robert F Director | Echo Therapeutics, Inc. (ECTE) | 12-Mar-13 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 11-Jan-13 9:47 AM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 10-Jan-13 | Grant | 6,250 | -- | -- | 3% 188.75K to 195.0K | |
| 11-Jan-13 9:50 AM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 10-Jan-13 | Grant | 6,250 | -- | -- | 10% 65.75K to 72.0K | |
| 11-Jan-13 9:49 AM View: | Enright Vincent D Director | Echo Therapeutics, Inc. (ECTE) | 10-Jan-13 | Grant | 6,250 | -- | -- | 3% 202.08K to 208.33K | |
| 26-Oct-12 5:00 PM View: | Schnittker Christopher P CFO | Echo Therapeutics, Inc. (ECTE) | 24-Oct-12 | Grant | 62,500 | -- | -- | 100% 62.5K to 125.0K | |
| 26-Oct-12 5:00 PM View: | Burke Kimberly A General Counsel | Echo Therapeutics, Inc. (ECTE) | 24-Oct-12 | Grant | 75,000 | -- | -- | 30% 250.0K to 325.0K | |
| 26-Oct-12 5:00 PM View: | Mooney Patrick T CEO and President Director | Echo Therapeutics, Inc. (ECTE) | 24-Oct-12 | Grant | 150,000 | -- | -- | 8% 1.88M to 2.02M | |
| 02-Oct-12 4:15 PM View: | Enright Vincent D Director | Echo Therapeutics, Inc. (ECTE) | 30-Sep-12 | Grant | 6,250 | -- | -- | 3% 195.83K to 202.08K | |
| 02-Oct-12 4:15 PM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 30-Sep-12 | Grant | 6,250 | -- | -- | 3% 182.5K to 188.75K | |
| 02-Oct-12 4:15 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 30-Sep-12 | Grant | 6,250 | -- | -- | 11% 59.5K to 65.75K | |
| 23-Aug-12 1:42 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 23-Aug-12 | Market Purchase | 6,400 | $1.47 | $9,408.00 | 12% 53.1K to 59.5K | (98%) |
| 23-Aug-12 1:42 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 22-Aug-12 | Market Purchase | 13,600 | $1.47 | $19,992.00 | 34% 39.5K to 53.1K | (98%) |
| 03-Jul-12 4:05 PM View: | Grieco William Director | Echo Therapeutics, Inc. (ECTE) | 30-Jun-12 | Grant | 6,250 | -- | -- | 4% 176.25K to 182.5K | |
| 03-Jul-12 4:05 PM View: | Smith James Francis Director | Echo Therapeutics, Inc. (ECTE) | 30-Jun-12 | Grant | 6,250 | -- | -- | 19% 33.25K to 39.5K | |
| 03-Jul-12 4:05 PM View: | Enright Vincent D Director | Echo Therapeutics, Inc. (ECTE) | 30-Jun-12 | Grant | 6,250 | -- | -- | 3% 189.58K to 195.83K |
